1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Golden Valley Development, Inc

Golden Valley Development, Inc

GVDI
Golden Valley Development, IncUS flagOther OTC
0.01
USD
- -
- -
2.17MMarket Cap
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
TTM
Revenue per Share
1,142.86
- -
722.57
- -
116.57
26
4.65
Basic EPS, GAAP
562.86
-2,236.71
-3,659.14
- -
-3,731.57
-15,415.83
-17,125.55
Free Cash Flow per Basic Share
1,142.86
-1,767.71
-2,320.71
- -
-2,679.14
-1,448.83
-1,595.81
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
6,512.86
4,040.57
381.43
- -
-7,013.86
-17,007.25
-20,733.19
Tangible Book Value per Share
798.57
-730.71
-2,777
- -
-8,515.29
-6,995.25
-8,881.06
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
65.74
- -
-436.93
-168.01
-2,874.75
-58,192.95
-360,658.33
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
14.99
- -
- -
- -
- -
- -
- -
Profit Margin (%)
49.25
- -
-506.41
-192.98
-3,201.1
-59,291.67
-368,675
Working Capital
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-42.39
-165.5
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'09
Mar'10
Jun'10
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Dec'09
Mar'10
Jun'10
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
56.37%
40.83%
Free Cash Flow
- -
-43.04%
-7.29%
Net Income, GAAP
- -
35.41%
608.2%
Sales/Revenue/Turnover
- -
- -
-61.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
-1,654.57
-486.57
-996.14
- -
-3,731.57
2009
-863.71
-863.71
-876.29
- -
-15,415.83
2010
-236.83
-236.83
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Kevin Sorrels
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
611 South Fort Harrison Avenue Clearwater FL United States of America 33756
IPO Date
Dec 17, 2007
Website
goldenvalleydv.com
Similar Companies
Straumann Holding AG (SAUHY)
SKAN Group AG (SKAN.SW)
Bioteque Corporation (4107.TWO)
Doxa AB (publ) (DOXA.ST)
bonyf N.V. (MLBON.PA)
UG Healthcare Corporation Limited (8K7.SI)
Business
Golden Valley Development, Inc. (GVDI) is a publicly traded holding company that, through its subsidiaries, provides digital marketing consulting services to businesses seeking to enhance their online presence and customer reach; it also manufactures and markets patented healthcare and consumer products, including Percuguard and Cutstop finger guards designed to protect against cuts from knives and sharp implements in healthcare, hospitality, and home settings. Founded in 2004 and headquartered at 611 South Fort Harrison Avenue, Suite 380, Clearwater, Florida, the company operates primarily in the United States across healthcare equipment, digital services, and media consultancy segments, where it identifies entertainment and sports industry participants for joint venture marketing and entertainment projects. In its most recent quarterly disclosure for Q1 2024, Golden Valley reaffirmed its focus on digital marketing operations amid a strategic shift from earlier healthcare product emphases, with no major acquisitions, funding rounds, or new product launches reported in 2024 or 2025; the firm trades on OTC Pink Sheets with a market capitalization of approximately $14 million as of late 2025.